Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 13 min 20 sec ago

Endo Announces Launch Of BELBUCA(TM) (Buprenorphine) Buccal Film For Chronic Pain Management

Mon, 02/22/2016 - 17:47
New opioid analgesic with novel drug delivery now available by prescription in U.S. DUBLIN, Feb. 22, 2016 -- (Healthcare Sales & Marketing Network) -- Endo Pharmaceuticals Inc., a subsidiary of Endo International plc (ENDP) (ENL.TO), today announced th...
Biopharmaceuticals, Drug Delivery, Product Launch
Endo International, BELBUCA, buprenorphine, buccal film

Boston Scientific Receives CE Mark For Eluvia(TM) Drug-Eluting Vascular Stent and Announces Initiation of New Clinical Trial

Mon, 02/22/2016 - 15:45
First polymer-based, drug-eluting stent designed to treat peripheral lesions above the knee approved in Europe; IMPERIAL trial initiated to seek regulatory approvals in U.S. and Asia MARLBOROUGH, Mass., Feb. 22, 2016 -- (Healthcare Sales & Marketing Net...
Devices, Interventional, Regulatory, Product Launch
Boston Scientific, Eluvia, Drug Eluting Stent

Cipher Pharmaceuticals Inc. announces Canadian launch of Actikerall(TM)

Mon, 02/22/2016 - 13:42
MISSISSAUGA, ON, Feb. 22, 2016 -- (Healthcare Sales & Marketing Network) - Cipher Pharmaceuticals Inc. (NASDAQ:CPHR; TSX:CPH) ("Cipher" or "the Company") today announced the Canadian launch of Actikerall™ (0.5% fluorouracil and 10% sal...
Biopharmaceuticals, Dermatology, Product Launch
Cipher Pharmaceuticals, Actikerall, hyperkeratotic actinic keratosis

Vertice Pharma appoints Scott Meyers as Chief Operating Officer

Mon, 02/22/2016 - 13:36
BERKELEY HEIGHTS, N.J., Feb. 22, 2016 -- (Healthcare Sales & Marketing Network) -- Vertice Pharma today announced the appointment of Scott Meyers as Chief Operating Officer. "We are pleased to welcome Scott to the Vertice Pharma leadership team. S...
Biopharmaceuticals, Personnel
Vertice Pharma

Lannett Receives FDA Approval For Sumatriptan Nasal Spray USP, 5mg And 20mg

Mon, 02/22/2016 - 13:29
PHILADELPHIA, Feb. 22, 2016 -- (Healthcare Sales & Marketing Network) -- Lannett Company, Inc. (LCI) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Sumatrip...
Biopharmaceuticals, Generics, FDA
Lannett Company, GlaxoSmithKline, Sumatriptan, Imitrex

Amgen And UCB Announce Positive Top-Line Results From The Phase 3 Study Of Romosozumab In Postmenopausal Women With Osteoporosis

Mon, 02/22/2016 - 13:14
FRAME Study Met All Primary Endpoints by Reducing the Incidence of New Vertebral Fracture Through 12 and 24 Months THOUSAND OAKS, Calif. and BRUSSELS, Feb. 22, 2016 -- (Healthcare Sales & Marketing Network) -- Amgen (AMGN) and UCB (Euronext Brussels: U...
Biopharmaceuticals
Amgen, UCB , osteoporosis, romosozumab, FRAME study

Veracyte Announces Publication of Study Reinforcing the Clinical Utility of the Afirma(R) Gene Expression Classifier in Thyroid Cancer Diagnosis

Fri, 02/19/2016 - 13:31
SOUTH SAN FRANCISCO, Calif., Feb. 19, 2016 -- (Healthcare Sales & Marketing Network) -- Veracyte, Inc. (VCYT), a molecular diagnostics company pioneering the field of molecular cytology, announced that an independent clinical utility study reinforcing the...
Diagnostics, Oncology
Veracyte, Afirma GEC, Thyroid Cancer

eFFECTOR Therapeutics Increases its Series B Financing Round to $56M

Fri, 02/19/2016 - 13:24
SAN DIEGO, Feb. 19, 2016 -- (Healthcare Sales & Marketing Network) -- eFFECTOR Therapeutics, Inc., a biopharmaceutical company developing selective translation regulators for the treatment of cancer, today announced it has increased its Series B financing...
Biopharmaceuticals, Oncology, Venture Capital, Personnel
eFFECTOR Therapeutics, eFT508, MNK1, MNK2, lymphoma

Nipro Medical Corporation Launches the Cronus(TM) HP 0.035" OTW PTA Balloon Catheter in the United States

Fri, 02/19/2016 - 13:16
BRIDGEWATER, N.J., Feb. 19, 2016 -- (Healthcare Sales & Marketing Network) -- Nipro North America, a division of Nipro Medical Corporation, announced the launch of the Cronus HP high-pressure, 0.035" over-the-wire (OTW) percutaneous transluminal angi...
Devices, Interventional, Product Launch
Nipro Medical, Cronus HP, balloon catheter, angioplasty

Novogen Patent Covering Cantrixil and Trilexium has Proceeded to Grant

Fri, 02/19/2016 - 13:09
Cornerstone patent covering Cantrixil and Trilexium granted in Australia Patent provides composition of matter, method of manufacture, and method of use protection out to 2035 Cornerstone patent covering Anisina accepted in Australia and moves into s...
Biopharmaceuticals, Oncology
Novogen, superbenzopyran, Cantrixil, Trilexium

Nipro Medical Corporation Launches the AQUALiner II Second Generation 0.035" Hydrophilic, Super-Elastic Nitinol Guidewire in the United States

Thu, 02/18/2016 - 21:24
BRIDGEWATER, N.J., Feb. 18, 2016 -- (Healthcare Sales & Marketing Network) -- Nipro North America, a division of Nipro Medical Corporation, announced the launch of the AQUALiner II second generation 0.035" hydrophilic, super-elastic Nitinol guidewire...
Devices, Interventional, Cardiology, Product Launch
Nipro Medical, AQUALiner, guidewire, nitinol

Nipro Medical Corporation Launches the AQUALiner II Second Generation 0.035" Hydrophilic, Super-Elastic Nitinol Guidewire in the United States

Thu, 02/18/2016 - 19:53
BRIDGEWATER, N.J., Feb. 18, 2016 -- (Healthcare Sales & Marketing Network) -- Nipro North America, a division of Nipro Medical Corporation, announced the launch of the AQUALiner II second generation 0.035" hydrophilic, super-elastic Nitinol guidewire...
Devices, Interventional, Cardiology, Product Launch
Nipro Medical, AQUALiner, guidewire, nitinol

Philips and Hitachi Data Systems to Deliver Next-Generation Data Management Solution for Healthcare Organization-Wide Access to Billions of Medical Images

Thu, 02/18/2016 - 13:05
New Vendor Neutral Archiving solution delivers medical images from all disciplines to clinicians across multiple departments and locations within the health system in less than 3 seconds Powered by Philips' HealthSuite digital platform, solution combine...
Devices, Radiology
Royal Philips, Hitachi, imaging

Protagonist Therapeutics Names Thomas P. O'Neil Chief Financial Officer

Wed, 02/17/2016 - 15:30
MILPITAS, Calif., Feb. 17, 2016 -- (Healthcare Sales & Marketing Network) -- Protagonist Therapeutics, Inc., a clinical stage company developing novel, orally-stable peptide therapeutics for gastrointestinal (GI) diseases, today announced the appointment ...
Biopharmaceuticals, Gastroenterology, Personnel
Protagonist Therapeutics, inflammatory bowel disease

New OneTouch Verio Flex(TM) Blood Glucose Meter Takes the Guesswork Out of Blood Sugar Test Results

Wed, 02/17/2016 - 15:28
BURNABY, BC , Feb. 17, 2016 (Healthcare Sales & Marketing Network) - LifeScan Canada, a division of Johnson & Johnson Inc. is pleased to introduce the new OneTouch Verio Flex™ blood glucose meter, the latest addition to the OneTouch Verio® family of m...
Devices, Monitoring, Endocrinology, Product Launch
LifeScan, Johnson & Johnson, OneTouch, Verio Flex, blood glucose

Z-Medica Receives Expanded CE Mark for QuikClot(R)

Wed, 02/17/2016 - 15:24
WALLINGFORD, Conn., Feb. 17, 2016 -- (Healthcare Sales & Marketing Network) -- Z-Medica®, LLC, a leading developer and marketer of hemostatic devices, announces today they have received an expanded CE Mark for their QuikClot® products in the Europe...
Devices, Regulatory
Z-Medica, QuikClot, hemostatic, hemostasis

Impax Receives FDA Approval for Generic Version of Adderall XR(R) (mixed salts of a single-entity amphetamine product) Capsules, CII

Wed, 02/17/2016 - 15:19
HAYWARD, Calif., Feb. 17, 2016 -- (Healthcare Sales & Marketing Network) -- Impax Laboratories, Inc. (IPXL) today announced that the U.S. Food and Drug Administration (FDA) has approved its Abbreviated New Drug Application (ANDA) for dextroamphetamine sac...
Biopharmaceuticals, Generics, FDA
Impax Laboratories, Adderall XR, amphetamine

Terumo Cardiovascular Group Introduces the CAPIOX(R) FX Advance Oxygenator

Wed, 02/17/2016 - 13:47
ANN ARBOR, Mich., Feb. 17, 2016 -- (Healthcare Sales & Marketing Network) -- Terumo Cardiovascular Group (Terumo CV Group) introduces the newest addition to the CAPIOX® Oxygenator portfolio – the CAPIOX FX Advance Oxygenator. The CAPIOX FX Advance rep...
Devices, Product Launch
Terumo Cardiovascular, CAPIOX Oxygenator, CAPIOX FX

Interpace Diagnostics Receives Medicare Coverage For Its ThyraMIR(TM) Micro RNA Gene Expression Classifer

Wed, 02/17/2016 - 13:41
PARSIPPANY, N.J., Feb. 17, 2016 -- (Healthcare Sales & Marketing Network) -- Interpace Diagnostics Group Inc. (IDXG), a fully integrated molecular diagnostics company focused on developing and commercializing innovative diagnostic tests, announced today t...
Diagnostics, Oncology, Reimbursement
Interpace Diagnostics, ThyraMIR, ThyGenX, PancraGen

BD Receives FDA 510(k) Clearance for New Blood Collection Device to Help Enhance Patient and Clinician Experience

Wed, 02/17/2016 - 13:34
Novel PentaPoint™ Comfort and RightGauge™ Needle Technologies Help Improve Comfort, Access to Difficult Veins FRANKLIN LAKES, N.J., Feb. 17, 2016 -- (Healthcare Sales & Marketing Network) -- BD (Becton, Dickinson and Company) (BDX), a leading global me...
Devices, FDA
BD , PentaPoint, RightGauge Needle, Vacutainer

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong